Olmesartán/Hidroclorotiazida Pensa Pharma (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartán/Hidroclorotiazida Pensa Pharma, is a angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension, often in combination with a thiazide diuretic, and is indicated for adults. GNH USA supplies Olmesartán/Hidroclorotiazida Pensa Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartán/Hidroclorotiazida Pensa Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan/hydrochlorothiazide is used primarily for hypertension management, acting on the renin‑angiotensin‑aldosterone system and fluid balance.

- Hypertension: lowers systolic and diastolic blood pressure in patients with primary hypertension. - Heart failure adjunct: assists in blood‑pressure control when combined with other heart‑failure therapies. - Diabetic nephropathy risk reduction: helps reduce progression of kidney damage in patients with type 2 diabetes and hypertension. - Stroke‑prevention post‑event: contributes to secondary prevention of stroke by maintaining target blood‑pressure levels. - Chronic kidney disease: supports blood‑pressure control in patients with early‑stage chronic kidney disease.

Common Side Effects: - Headache  - dizziness  - fatigue  - increased potassium 

Serious or Rare Side Effects: - angio  y                     -                          -  ...

Olmes

...